Partial
Mostly Aligned
Patient Risk:
Low
Summary
The evaluation correctly identifies a key naming discrepancy (Kapspargo Cap vs Kapspargo Sprinkle) and supports for 'Take as prescribed', but it contains several unsupported claims and omits critical safety elements present in the FDA label (contraindications, boxed warnings, pregnancy and pediatric use, and complete dosing/counseling details). Overall, partial alignment.
Category Scores
Accurate Statements
Take as prescribed.
supported
Unsupported Statements
The same 25 mg strength can exist for different drugs.
Not supported by the supplied prescribing information.
Do not crush or open capsules unless your clinician told you to.
Not explicitly supported; label discusses administration but does not state this blanket instruction.
Don't share medications with others.
Not present in the provided label sections.
If you're unsure or the pill looks different from your bottle, check with your pharmacist or doctor before taking it.
Not present in the provided label sections.
Contradictions
Low
AI Statement
Kapspargo Cap 25 mg is a brand-name capsule.
Label Reference
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL - 25 mg
Important Omissions
Important safety elements required by FDA labeling for metoprolol succinate ER are not addressed: contraindications, boxed warnings, pregnancy, pediatric use, and other safeguards; dosing specifics and complete patient counseling are incomplete.
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
The evaluation identifies some alignment but also critical safety omissions not covered by the provided label sections.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Omissions of contraindications/boxed warnings/use in pregnancy and pediatric populations; mislabel name (Cap vs Sprinkle); lack of explicit guidance on sharing and appearance verification.
Suggested Improvement
Incorporate and reference complete FDA labeling sections (4 CONTRAINDICATIONS; 5 WARNINGS AND PRECAUTIONS; 8 USE IN PREGNANCY; 8.1 Pediatric Use; 2 DOSAGE AND ADMINISTRATION; 17 PATIENT COUNSELING INFORMATION). Correct product naming to Kapspargo Sprinkle and ensure administration details (including sprinkling guidelines and cautions) align with the label.